Non-Executive Directors
Tessa Green CBE
Chairman
R ICR (alternate) QAR I
Tessa Green became Chairman of The Royal Marsden NHS Foundation Trust in November 1998. She was appointed Chairman of The Royal Marsden NHS Foundation Trust in April 2004, and reappointed in December 2005 for a further three years with effect from 1 November 2006. Previously she was a Non-Executive Director of The Royal Berkshire and Battle Hospitals NHS Trust in Reading and Chairman of the Research Ethics Committee at The Royal Marsden. Tessa worked in the media until 1990 as Head of Corporate Communications for Carlton Communications plc. In 1991 she embarked on a law degree and was called to the Bar in 1994. She was awarded a CBE in The Queen's Birthday Honours of 2008.
Gregory Andrews, FCA
R A I QAR
Greg has spent most of his career in financial services. He was with Merrill Lynch for 20 years where he held a number of positions including that of Managing Director of Merrill Lynch International Bank Limited and as Chief Financial Officer of Merrill’s Global Private Banking Group in New York. From 2002 to 2006 he was Chief Operating Officer of New Philanthropy Capital, and now runs his own consulting business specialising in change management. He is a Governor of Epsom College and advisor to and Trustee of a number of charities. He is Chair of The Royal Marsden’s Audit Committee and the Investment Committee and is a Trustee of The Royal Marsden Cancer Campaign.
Colin Clark
R A QAR
Colin Clark has had over 25 years' experience in the investment management industry with Mercury Asset Management and Merrill Lynch Investment Managers. He is a Director of Aida Capital Ltd and a Non-Executive Director of Standard Life Investments and Alpha Strategic plc. He is a Governor of Francis Holland School and a founder shareholder in Notting Hill Preparatory School.
Sir John Craven
QAR
Sir John was Chairman of Fleming Family and Partners Limited, an independent, privately-owned investment house and was the Group Chief Executive and Chairman of Morgan Grenfell Group plc and a Member of the Board of Managing Directors of Deutsche Bank AG after that company’s acquisition of Morgan Grenfell. Sir John holds both British and Canadian nationality and was knighted for his services to banking and to the City.
Rev. Dame Sarah Mullally R A E QAR
Rev Dame Sarah Mullally was Chief Nursing Officer for England/Director of Patient Experience until September 2004 and Assistant Curate at Battersea Fields Benefice, London until September 2006. She is now Rector for the Church of England Team Ministry in Sutton.
Professor Peter Rigby
QAR A ICR
Professor Rigby is Chief Executive of The Institute of Cancer Research, where he is responsible for a major programme of cancer research which extends from basic laboratory science through translational research to clinical implementation. He is a Fellow of the Academy of Medical Sciences.
Richard Turnor
Richard Turnor has been a partner at law firm Allen & Overy since 1985 where he advises professional firms and fund managers on structuring and constitutional issues. He is also a founder committee member and former chairman of the Association of Partnership Practitioners. After six years as vice chair at The Royal Marsden Cancer Campaign, he became a director of The Royal Marsden NHS Foundation Trust in 2009.
Executive Directors
Cally Palmer CBE
Chief Executive
ICR QAR I
Cally Palmer became Chief Executive of The Royal Marsden in 1998. Previously Cally was Deputy Chief Executive and Director of Services at the Royal Free Hampstead NHS Trust. Cally is an MSc graduate in management from the London Business School, which she gained with distinction in 1995, and a member of the Institute of Health Services Management. Cally was awarded a CBE in 2006 for her contribution to the NHS.
David Probert
Chief Operating Officer
E QAR
David Probert joined The Royal Marsden in October 2007 as its first Chief Operating Officer. Having completed his MBA with distinction in 1998, David joined the NHS Management Training Programme working in a mixture of community and acute settings including a period of time with the world renowned Institute of Healthcare Improvement in Boston, USA. Following that he joined Guy's and St Thomas' NHS Trust as a Deputy General Manager being promoted to General Manager in 2003. David joined The Royal Marsden having held the position of Divisional General Manager / Deputy Divisional Director at Guy’s and St Thomas’ NHS Foundation Trust for almost four years.
Mr Alan Goldsman
Director of Finance
I A
Alan Goldsman was appointed in 2002 from Guy’s and St Thomas’ NHS Trust where he was Deputy Director of Finance. Prior to this, Alan’s career includes four years in senior finance roles with the Health Service in New Zealand, and a further four years spent in the construction industry and in commercial banking. Alan is a qualified accountant and has an MSc in Health Management from City University.
Professor Martin Gore
Medical Director
QAR
Professor Martin Gore qualified in medicine at St Bartholomew’s Hospital, London in 1974. He trained in General Internal Medicine for five years and then was appointed as a Clinical Scientist at the Ludwig Institute of Cancer Research (1981&ndash4). In 1984, he joined the training programme at The Royal Marsden and was appointed Consultant Cancer Physician to The Royal Marsden Hospital and Senior Lecturer at The Institute of Cancer Research in 1988. He is on the editorial board of several journals and has published over 300 articles and edited seven textbooks. He is currently Chairman of the Department of Health’s Gene Therapy Advisory Committee and Vice-Chairman of the Health and Safety Executive’s Scientific Advisory Committee on Genetically Modified Organisms.
Shelley Dolan
Chief NurseICR A QAR
Shelley Dolan was appointed to the role of Chief Nurse at The Royal Marsden NHS Foundation Trust in June 2007. She has worked clinically in the field of intensive care for 20 years, is a trained Intensive Care and Cancer Nurse who achieved her MSc in Cancer Care in 1996. She was promoted to Chief Nurse from her position as the first Nurse Consultant in Critical Care in the UK, a role she took up at The Royal Marsden in 2000. Prior to that, she was a Staff Nurse, Sister, Clinical Tutor and a Clinical Nurse Specialist. Shelley is currently completing her Doctorate in Nursing Science this year and is also Chair of the Royal College of Nursing Cancer Nursing Forum and the Local Research Ethics Committee. She is also Vice Chair of the Department of Health’s Medicines and Healthcare products Regulatory Agency, and sits on the Board of the International Society of Nurses in Cancer Care and on the Advisory Board of the European Oncology Nursing Society.
Other members of the Management Executive
Nicky Browne
Director of Performance & Strategy Implementation
Gary Burkill
Head of Facilities
Anne Carey
Divisional Director, Cancer Services
Ian Haig
Divisional Director, Clinical Services
QAR
Kerensa Heffron
Development Director of Business and Private Practice
Dr Stephen Johnston
Director of Clinical Research & Development QAR
Jon Reed
Director of ICT
Rachael Reeve
Director of Marketing and Communications
Colin Rickard
Director of Capital Projects
David Svenson
Interim Director of Estates
Deborah Tarrant
Director of Workforce and Corporate Affairs
QAR E
Key
- R – Member of Remuneration and Terms of Service Committee
- A – Member of Audit Committee
- I – Member of Investment Committee
- E – Member of Equality and Diversity Committee (formerly Equalities Taskforce)
- ICR – Member of the Board of Trustees of The Institute of Cancer Research
- QAR – Member of Quality, Assurance and Risk Committee